β-Adrenergic Receptor Inhibitor and Oncolytic Herpesvirus Combination Therapy Shows Enhanced Antitumoral and Antiangiogenic Effects on Colorectal Cancer

• Main Authors: Jiali Hu (Author), Cuiyu Chen (Author), Ruitao Lu (Author), Yu Zhang (Author), Yang Wang (Author), Qian Hu (Author), Wanting Li (Author), Shiyu Wang (Author), Ouyang Jing (Author), Hanying Yi (Author), Wei Zhang (Author), Ling Chen (Author), Weihua Huang (Author), Jia Luo (Author), Howard L. McLeod (Author), Ran Xu (Author), Yijing He (Author)
• Format: Book
• Published: Frontiers Media S.A., 2021-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Oncolytic viruses (OVs) are considered a promising therapeutic alternative for cancer. However, despite the development of novel OVs with improved efficacy and tumor selectivity, their limited efficacy as monotherapeutic agents remains a significant challenge. This study extended our previously obse...